Ravis W R, Chen C Y
J Pharm Sci. 1981 Dec;70(12):1353-7. doi: 10.1002/jps.2600701217.
The dissolution characteristics of dicumarol were markedly enhanced by preparing dispersions of drug in polyethylene glycol 4000. Solid dispersions of varying weight fractions were formed by a melt method without measurable drug degradation or evaporation. There were no significant differences in dissolution rates among weight fractions, with dynamic solubilities being approximately 2.5 times greater than dicumarol's equilibrium solubility. No indications of drug polymer complexation were noted from equilibrium or in situ absorption experiments. Incorporation of solid dispersions into direct compression tablets provided dosage forms with fast-release properties relative to test tablets of physical mixtures and a commercially available product. Percentages dissolved in 30 min were 370% greater for 1:3 and 1:5 (w/w) solid dispersion tablets compared to a commercial tablet at 37 degrees with a pH 7.5 dissolution buffer. X-ray diffraction of test powder revealed that the crystalline nature of the drug had altered during fusion preparation. Dissolution traits and drug stability for solid dispersions were maintained over 1 year of storage.
通过制备双香豆素在聚乙二醇4000中的分散体,双香豆素的溶解特性显著增强。采用熔融法形成了不同重量分数的固体分散体,药物没有明显降解或挥发。各重量分数之间的溶解速率没有显著差异,动态溶解度约为双香豆素平衡溶解度的2.5倍。平衡或原位吸收实验均未发现药物聚合物络合的迹象。将固体分散体加入直接压片制成的剂型相对于物理混合物的测试片和市售产品具有速释特性。在37℃、pH 7.5的溶解缓冲液中,1:3和1:5(w/w)固体分散体片在30分钟内的溶出百分比比市售片高370%。测试粉末的X射线衍射显示,药物在熔融制备过程中结晶性质发生了改变。固体分散体的溶解特性和药物稳定性在储存1年后仍能保持。